“If That Is Not Extortion, What Is?” SC Questions ₹2,700 Cancer Drug With ₹27,000 MRP
GUWAHATI: The Supreme Court on Tuesday questioned the wide disparity between the price at which manufacturers sell medicines to retailers and the maximum retail price (MRP), citing an example of a cancer medicine sold to a retailer for ₹2,700 while carrying an MRP of ₹27,000. ALSO READ: Centre Warns Against Indiscriminate Use of Painkillers, Antibiotics…